- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA found Teva in breach for DuoResp Spiromax website when viewed on mobile: mobile/desktop final forms differed but weren’t separately certified, and…
Kesimpta promo webpage implied unrestricted SMC approval (restriction not in immediate view). A UK HCP banner ad omitted “adult” from the licence…
Novartis’ Entresto HCP website claim that national guidelines support 1st line use in chronic HFrEF was ruled insufficiently complete for a broad…
Novartis certified a MailOnline MS disease-awareness article, but the PMCPA found the social share templates generated by share buttons weren’t certified. Breach…
Dr Falk was ruled in breach of Clause 5.1 after a Budenofalk digital ad remained in use 12 weeks after agreeing to…
AAA’s RLT Hub stated Pluvicto was not licensed in Northern Ireland after EMA approval. PMCPA found the statement inaccurate/out-of-date and criticised website…
Anonymous complaint alleged a Phase 2/3 sarcoma trial flyer in conference bags was pre-licence promotion and inappropriately distributed. Panel found the content…
A member of the public challenged GSK’s press release for quoting vaccine “efficacy” percentages without absolute risk/context. PMCPA ruled the presentation could…
A UK-based AstraZeneca employee ‘liked’ a US colleague’s LinkedIn post linking to a Breztri press release. The Panel ruled this proactively disseminated…
PMCPA ruled GSK’s Trelegy HCP webpage claim “greater exacerbation reduction vs another single-inhaler triple therapy” was ambiguous and misleading, implying significance without…
Anonymous complaint alleged Daiichi Sankyo covertly recorded HCP calls using an AI tool. Panel found no evidence of covert recording and accepted…
Novo Nordisk was ruled in breach for failures to disclose, late disclosure, and inaccurate/misplaced reporting of transfers of value to HCOs and…
Complaint alleged a Rosemont LinkedIn post and website content promoted a specific POM to the public and lacked certification. Panel found the…
AbbVie failed to recertify an AbbVie Pro “Oncology Focus Area” landing page within the required two-year interval. PMCPA found a breach of…
Complaint alleged pre-licence promotion via a LinkedIn post linking to a GSK press release about Aiolos Bio acquisition and AIO-001 in asthma.…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.